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Abstract
Background: Cardiac surgery patients at very high risk are difficult to stratify with the existing risk scores. The
objective of this study is to assess the clinical performance of two existing risk stratification scores (EuroSCORE II
and ACEF score) in the setting of very high-risk patients undergoing cardiac surgery, and to identify a possible
strategy to better address this patient population.
Methods: Three-thousand-four-hundred-twenty eight (3,428) consecutive adult patients receiving cardiac operations
at a single institution were investigated. Patients having an operative mortality risk >25 % at either the EuroSCORE II
or the ACEF score were selected (105 patients). The discrimination power and calibration of the EuroSCORE II and the
ACEF score were investigated. Factors associated with operative mortality were included in a multivariable logistic
regression model and a new model was re-built for this patient population.
Results: The observed mortality rate was 26 %. The expected mortality rate was underestimated by the EuroSCORE II
(16 %) and overestimated by the ACEF Score (36 %). The EuroSCORE maintained a good discrimination (c-statistics 0.75)
while the ACEF score did not (c-statistics 0.52). Within this patient population, the independent risk factors for operative
mortality were emergency surgery, serum creatinine levels, pulmonary hypertension, and preoperative anemia.
A model based on these factors provided an expected mortality risk of 26 % with a good discrimination (c-statics 0.82).
Applying this model to extremely high-risk patients (expected mortality rate > 50 %) resulted in the re-classification of
25 % of the patient population.
Conclusions: The existing risk models have a poor clinical relevance in the segment of patients at very high mortality
risk. This is particularly frustrating, because these patients are those where the decision-making process is
more important. A two-stage classification strategy (first stage: EuroSCORE II/ACEF score risk > 25 %; second
stage: reclassification based on pulmonary hypertension, serum creatinine, and anemia) seems a possible
strategy to correctly address very high-risk patients.
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Background
Risk stratification in cardiac surgery patients is usually
performed using the three risk stratification scores re-
cently accepted by the joint guidelines of the European
Association for Cardio-Thoracic Surgery (EACTS) and
the European Society of Cardiology (ESC) [1]. These are
the European System for Cardiac Operative Risk Evalu-
ation version II (EuroSCORE II) [2], the STS-PROM
Score [3], and the age, creatinine, ejection fraction (ACEF)
score [4].
The recently released EuroSCORE II is probably the
most widely used mortality risk scoring system in
Europe. However, a number of studies have underlined
its underestimation of the mortality risk in high-risk
cardiac surgery patients. The first validation study,
published a few months after the publication of the
EuroSCORE II, confirmed the good discriminative
power of this tool (c-statistics 0.81), but noticed that
in very high-risk patients the observed mortality rate
(11 %) was higher than the expected (6.5 %) [5]. Sub-
sequently, other studies confirmed similar findings: in
combined cardiac surgery, the observed mortality rate
was almost double the expected [6]; in urgent and
emergent procedures the observed mortality rate
exceeded the expected by 43 % and 45 % respectively
[7], and by 25 % in high-risk (expected mortality
rate > 9.2 %) patients [7]. In another series, the observed
mortality (28 %) was double the expected (14 %) in patients
with an expected mortality > 10 % [8]. The underestimation
of mortality in high-risk patients was confirmed in a large
UK series [9] and by a recent meta-analysis [10].
Losing reliability of mortality risk prediction in high- or
very-high risk patients is frustrating for cardiac surgeons.
The segment of patients with an expected mortality
rate >20 %–25 % represents a challenge for the thera-
peutic decision-making process. Within this patient
population, different options are often viable: conventional
surgery; alternative procedures like transcatheter aortic
valve replacement or mitral valve repair; aortic valve bal-
loon angioplasty; percutaneous transluminal coronary
angioplasty; and pharmacological therapy. Therefore,
there is an unmet need for an accurate surgical mortality
risk prediction.
The aims of the present study are (i) to verify if the
existing risk scores are actually unreliable within the seg-
ment of patient population at very high surgical mortal-
ity risk, and (ii) to search additional factors which may




This is a retrospective cohort study based on our institu-
tional database for cardiac surgery patients. The period
considered was October 2011 to January 2015. In this
period, all the patients received a preoperative risk as-
sessment based on the EuroSCORE II, plus the usual
ACEF Score assessment already in place at our institu-
tion since 2010. The STS-PROM is not routinely utilized
at our institution. The local ethics committee (IRRCS
San Raffaele Hospital) approved the experimental design
and waived the need for a written informed consent
from the patients, who however gave a written consent
to the scientific treatment of their data for scientific pur-
poses and in anonymous form.
Patients
During the time period considered 4,756 patient were
operated. Patients receiving surgery for congenital heart
disease were excluded (1,328 subjects). The remaining
3,428 patients were analyzed for operative mortality risk,
and the patients with an expected mortality risk > 25 % at
either the EuroSCORE II or the ACEF score were ex-
tracted and constituted the study group (105 subjects).
This was considered the first-stage risk assessment.
We did not include an assessment of the third accepted
risk stratification system (STS-PROM) in this patient
population. This is due to the fact that the STS-PROM
supports only a limited number of procedures (isolated
coronary surgery, isolated mitral/aortic valve surgery, and
combined coronary surgery +mitral/aortic valve surgery),
and in our series, 35 patients (33 %) did not belong to
these categories.
Data collection and definitions
All data were retrieved from our institutional database.
The EuroSCORE II was calculated for every single patient
enrolled in the series with the EuroSCORE II interactive
calculator, available online (www.euroscore.org). For each
patient the mortality risk was assessed with the ACEF
score too.
Preoperative data routinely collected in our institu-
tional database include all the risk factors considered in
the EuroSCORE II, plus a number of additional pre- and
intraoperative data. All the definitions are in agreement
with those reported in the original EuroSCORE II pres-
entation [2]. The postoperative outcome data included
low cardiac output state (inotropic drugs > 48 h), use of
intra-aortic balloon pump (IABP) or ventricular assist-
ance, acute kidney injury (AKI, defined as peak postop-
erative serum creatinine level > double the baseline),
stroke, surgical revision, mesenteric infarction, systemic
infections, and operative mortality (in-hospital or within
30 days from surgery for patients discharged).
The patient population was divided into two groups
(survivors and non-survivors) according to the presence
of operative mortality.
Ranucci et al. Journal of Cardiothoracic Surgery  (2016) 11:13 Page 2 of 8
Statistics
The EuroSCORE II and the ACEF score were assessed
for discrimination power and calibration in the study
population. Discrimination of each model was assessed
with Receiver Operating Characteristics (ROC) analyses
considering the area under the curve (AUC) and its
95 % confidence intervals. The calibration was assessed
with the Hosmer-Lemeshow test, and as a further measure
of calibration and clinical performance the expected
mortality rate was compared to the observed mortal-
ity rate in terms of percentage with 95 % confidence
interval.
The two groups (survivors and non-survivors) were ana-
lyzed for differences in preoperative variables. Differences
between frequencies were analyzed with a Pearson’s chi-
square, differences between continuous variables were
analyzed with a two-sided Student’s t test (for normally
distributed variables) and non-parametric tests (for non-
normally distributed variables).
Factors being associated with operative mortality at
the univariate analysis were entered into a multivariable
logistic regression analysis (stepwise forward) to check
their role as independent predictors of mortality. This
was expressed in terms of odds ratios with 95 % confi-
dence interval. To avoid overfitting of the model, a max-
imum of 1 factor per 10 mortality events was allowed.
Multicollinearity was checked.
This second-stage model of risk stratification was
assessed in terms of clinical performance using a ROC
analysis and re-classification tables.
All data were expressed as number and percentage
with 95 % confidence interval, mean and standard devi-
ation (SD) of the mean or median and interquartile
range when appropriate. All the tests are two-sided, and
a P value < 0.05 was considered significant. Statistical
analysis was performed using a computerized package
SPSS 13.0 (SPSS Inc, Chicago, IL).
Results
Out of the 105 patients who were defined at high
operative risk (>25 %) according to the EUROSCORE
II (n = 21); to the ACEF score (n = 78), or both (6),
27 (26 %) patients had the end-point of operative
mortality.
The preoperative profile and operative data of the
total patient population and of survivors/non survivors
are shown in Table 1. At an univariate analysis, the
patients who did not survive had a higher rate of pul-
monary hypertension (PH, systolic pulmonary artery
pressure > 55 mmHg), a higher serum creatinine value,
a lower preoperative hematocrit (HCT) and were more
likely to be operated under emergency conditions and
to receive isolated valve surgery.
Observed operative mortality and risk stratification
The observed mortality in our patient population was
26 %. This value was significantly (P < 0.05) underesti-
mated by the EuroSCORE II (expected mortality 16.5 %)
and significantly (P < 0.05) overestimated by the ACEF
score (expected mortality 36.2 %), see Fig. 1.
At the diagnostics statistics for prediction capacity, the
EuroSCORE II demonstrated a good discrimination ability
(c-statistics 0.75) with a chi-square value of 7.9 (P = 0.44)
at the Hosmer-Lemeshow calibration tests, whereas the





N = 105 N = 78 N = 27
Age (years) 74.5 (7.2) 74.9 (6.8) 73.5 (8.3) 0.404
Weight (kgs) 71.2 (12.9) 70.4 (11.6) 73.5 (16.2) 0.290
Gender female 27 (25.7) 18 (23.1) 9 (33.3) 0.293
Left ventricle EF (%) 26 (23–30) 25 (23–30) 26 (23–33) 0.514
Pulmonary hypertension 13 (12.4) 6 (7.7) 7 (25.9) 0.013
Recent (30 days) MI 7 (6.7) 6 (7.7) 1 (3.7) 0.474
Unstable angina 1 (1.0) 1 (1.3) 0 (0) 0.554
Congestive heart
failure
29 (27.6) 20 (25.6) 9 (33.3) 0.441
Cardiogenic shock 6 (5.7) 3 (3.8) 3 (11.1) 0.161
Intra-aortic balloon
pump
7 (6.7) 4 (5.1) 3 (11.1) 0.283
Active endocarditis 5 (4.8) 3 (3.8) 2 (7.4) 0.454
COPD 18 (17.1) 15 (19.2) 3 (11.1) 0.335
Previous CVA 10 (9.5) 8 (10.3) 2 (7.4) 0.664
Diabetes on medication 31 (29.5) 22 (28.2) 9 (33.3) 0.615
Serum creatinine
(mg/dL)
1.4 (1.2–1.8) 1.3 (1.2–1.6) 1.7 (1.4–1.9) 0.002
Serum bilirubin
(mg/dL)
0.5 (0.5–0.7) 0.5 (0.5–0.7) 0.5 (0.5–0.6) 0.957
Hematocrit (%) 35.8 (5.5) 36.5 (5.3) 34.0 (5.8) 0.047
Redo surgery 17 (16.2) 10 (12.8) 7 (25.9) 0.111
Urgent procedure 37 (35.2) 28 (35.9) 9 (33.3) 0.810
Emergent procedure 7 (6.7) 2 (2.6) 5 (18.5) 0.004
Isolated CABG 25 (23.8) 22 (28.2) 3 (11.1) 0.074
CABG +mitral valve 19 (18.1) 16 (20.5) 3 (11.1) 0.274
CABG + aortic valve 8 (7.6) 5 (6.4) 3 (11.1) 0.427
Mitral + aortic valve 5 (4.8) 3 (3.8) 2 (7.4) 0.454
Ascending aorta/arch 5 (4.8) 3 (3.8) 2 (7.4) 0.454
Isolated valve 23 (21.9) 13 (16.7) 10 (37.0) 0.027
Others 20 (19) 16 (20.5) 4 (14.8) 0.516
Data are number (%) or mean (standard deviation) or median
(interquartile range)
CABG coronary artery bypass graft, CVA cerebrovascular accident, COPD
chronic obstructive pulmonary disease, EF ejection fraction
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ACEF score had no discrimination ability (c-statistics
0.52) and a chi-square value of 9.8 (P = 0.20) at the
Hosmer-Lemeshow calibration test.
Multivariable model for second-stage risk stratification
The variables being significantly associated with opera-
tive mortality were entered into a multivariable logistic
regression analysis. Given the high level of statistical sig-
nificance, the serum creatinine level was maintained as
continuous variable. The preoperative HCT value was
analyzed for association with operative mortality using
the co-ordinates of a ROC analysis, in order to define an
optimal value for dichotomization. This was found at a
level of HCT < 34 % (sensitivity 67 %, specificity 67 %)
that was defined as preoperative anemia. Therefore, both
the presence of PH and anemia were entered into the
multivariable model that is shown in Table 2. In this
model, serum creatinine levels, the presence of anemia
and PH, and surgery under emergency conditions
remained independently associated with the operative
mortality risk, whereas isolated valve surgery did not.
This new model had a good discrimination (c-statistics
0.82), and a chi-square of 4.1 (P = 0.77) at the Hosmer-
Lemeshow calibration test. The expected mortality rate,
at this second-stage risk stratification, was 26.1 % (95 %
confidence interval 21.5 % - 30.6 %), in agreement with
the observed mortality rate of 26 %.
The mortality risk obtained with this two-stage risk
stratification model is graphically shown in Fig. 2, for a
patient not in emergency conditions, and according to
the presence of the different risk factors. A mortality risk
of 50 % is reached at a serum creatinine level of 3.8 mg/
dL in absence of other risk factors; at 2.4 mg/dL in pres-
ence of either anemia or PH; and at a level around
1.0 mg/dL in presence of both anemia and PH.
The exact level of predicted mortality risk can be cal-
culated according to the logistic equation:
Mortality risk %ð Þ ¼ 100  e
−3:73 þcreatinine  0:98þpulmonary hypertension1:4 þanemia1:3ð Þ
1þ e −3:73 þcreatinine 0:98þpulmonary hypertension1:4þanemia1:3½ ð Þ
where creatinine is expressed in mg/dL, pulmonary
hypertension and anemia are binary coded as 0 if absent
and 1 if present.
For practical purposes, this equation has been solved
(with approximation) for the different combination of
factors, as reported in Table 3.
A reclassification table was applied to the patient
population (overall and non-emergency cases). For the
purposes of this analysis, we considered the classification
into the category of extremely high mortality risk
(>50 %) (Table 4). In the overall population, at the first
and second stage of risk stratification there was the same
number of patients in the extremely high mortality risk
class (20 patients), but 26 (25 %) patients were re-
classified (12 in the lower class and 14 in the higher
Fig. 1 Observed and expected mortality according to the EuroSCORE II and the ACEF score
Table 2 Multivariable logistic regression model for operative
risk mortality in patients with a risk > 25 % at the first stage
Factor Regression
coefficient
Odds ratio 95 % C.I. P value
Pulmonary hypertension
(>55 mmHg)
1.40 4.1 1.1 – 15.2 0.037
Anemia (HCT < 34 %) 1.31 3.7 1.3 – 10.8 0.017
Serum creatinine (mg/dL) 0.98 2.7 1.2 – 6.1 0.020
Emergency surgery 2.90 18.1 2.9 – 114 0.002
Constant - 3.73
C.I. confidence interval, HCT hematocrit
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class). The observed mortality rate in the extremely
high-risk class was 35 % at the first and 70 % at the
second-stage classification.
When applied only to non-emergency cases (98 pa-
tients), the reclassification table attributed 19 patients to
the extremely high-risk class at the first stage, and 13 at
the second stage. Twenty (20.4 %) patients were re-
classified, 13 in the lower class and 7 in the higher class.
The observed mortality rate in the extremely high-risk
class was 42 at the first stage and 69 % at the second-
stage classification.
Discussion
Our study provides confirmation on the well established
limitations of the risk stratification scores in high-risk
cardiac surgery patients. The novel finding of our study
is that the adoption of a double-stage risk stratification
model might improve the performance of two of the
existing scores.
Risk stratification scores and high-risk patients in cardiac
surgery
The segment of cardiac surgery patients being at very
high-risk for operative mortality is a clinical environ-
ment where a correct risk stratification is of paramount
importance. Much more than in lower risk classes, pa-
tients at very high mortality risk pose to the surgeon a
difficult challenge, with different therapeutic options,
from conventional surgery to transcatheter procedures,
even including the possibility of excluding any invasive
procedure and limiting the treatment to pharmacological
options.
In a patient population with an operative mortality
risk > 25 % (based on two validated risk scores), our
study confirms that the existing risk models actually
offer little information and guidance to the clinicians,
leaving them to their clinical judgment in this difficult
scenario. The observed mortality rate was actually 28 %
less than the expected according to the ACEF score, and
more than 50 % higher than expected according to the
EuroSCORE II. This last figure is in agreement to what
reported by other authors [5–8] who highlighted that in
different populations of patients at high surgical risk, the
actual mortality exceeded the EuroSCORE II expected
mortality by 25 % to 100 %. With respect to the ACEF
score, our finding is different from what previously
observed in a large validation study, where in high-risk
patients the ACEF score was underestimating the
mortality risk [11].
Fig. 2 Operative mortality risk as obtained with the double-stage approach, according to serum creatinine levels and the presence of anemia and
pulmonary hypertension (PH), in the patients not in emergency conditions
Table 3 Predicted operative mortality according to the two-stage
model. Stage 2, to be applied in patients with a mortality risk > 25%
according to the EuroSCOREII and/or the ACEF Score (stage 1)







1.0 or less 5 % 20 % 50 %
1.5 10 % 30 % 60 %
2.0 15 % 40 % 70 %
2.5 20 % 50 % 80 %
3.0 30 % 65 % 90 %
3.5 40 % 75 % 92 %
4.0 or more 50 % 80 % 95 %
PH: pulmonary hypertension (systolic pulmonary pressure > 55 mmHg);
anemia: hematocrit < 34%
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There are many possible interpretation for the im-
pressive underestimation of the mortality risk offered
by the EuroSCORE II in very high-risk patients. In
general, every risk model based on logistic regression
analyses tends to reduce its calibration at the two ex-
tremes of the risk stratification. This is usually due to
the limited number of patients enrolled in the devel-
opment series being at very low or very high mortality
risk, and particularly applies to the very high risk
(>25 %) patients. Actually, these represented only 3 %
of our patient population. From the original Euro-
SCORE II article [2] it is difficult to extract the rate of
patients being at very high risk in the development
series, but the overall patient population is certainly
far different from our series, being (as a mean) 10 years
younger, having 25 % lower serum creatinine levels,
and a lower rate of comorbidities. Mean left ventricu-
lar ejection fraction is not reported in the original
EuroSCORE II article, but it was certainly much
higher than the very low value (median 26 %) reported
in our patient population. The group of patients we
focused on certainly represents a minority, whose
characteristics and risk factors are probably not cor-
rectly captured by the EuroSCORE II nor in other
existing risk models. Finally, it should be recognized
that the concept of mortality utilized in the Euro-
SCORE II refers to “hospital mortality”, whereas in
our series it is “in hospital or 30-days after surgery in
discharged patients”. There is a difference between
these two values, correctly underlined by the authors
of the EuroSCORE II [2], who could assess that 30-
days mortality is about 15 % higher than hospital
mortality. Even considering this adjustment, the
underestimation of the EuroSCORE II in our as in
other series of high-risk patients remains important
and should be considered an established concept.
With respect to the ACEF score, one of the determi-
nants of the mortality risk assessment is the ejection
fraction. Our patient population had a very low ejec-
tion fraction (12 patients < 20 % ejection fraction) and
this resulted in a high ACEF score. It is possible that
in a subgroup of patients having such a low ejection
fraction, the ACEF score may actually overestimate
the mortality risk; additionally, the same methodo-
logical considerations apply to the ACEF score as well
as to the EuroSCORE II.
The two-stage risk stratification approach
To overcome this problem in a minority of patient who
however deserve a specific tool for risk stratification, our
study applied a two-stage approach, based on conven-
tional risk scores (first stage) and further new risk strati-
fication (second stage) using pre-assessed or totally new
risk factors. Some of the independent risk factors found
in the second-stage model are already present in the
ACEF score (serum creatinine) and in the EuroSCORE
II (emergency surgery, serum creatinine as a determin-
ant of creatinine clearance, and PH). However, being
applied sequentially to the preliminary first-step screen-
ing, no intercorrelation concerns can be raised.
One more factor (preoperative anemia) is not included
either in the EuroSCORE II or the ACEF score. How-
ever, a number of recent studies have highlighted the
important role of this factor as an independent deter-
minant of operative mortality [12–15]. Severe anemia
(HCT < 30 %) carries an operative mortality risk that is
70 % higher than in patients without this risk factor [12],
and even patients with a moderate degree of anemia
(HCT 30 %–36 %) experience a significant higher opera-
tive mortality [12]. Other studies focused on coronary
surgery patients found similar results [13, 14] and a re-
cent study confirmed this finding in a large patient
population undergoing different types of cardiac opera-
tions [15]. Of notice, in our setting of very high-risk
patients, preoperative anemia seems to play an even
greater role in determining operative mortality. In ab-
sence of other risk factors (no PH and serum creatinine
1.0 mg/dL), the presence of anemia results in a four-
times higher mortality risk, and the difference remains
more than double at any serum creatinine level between
1.0 and 3.0 mg/dL. For higher serum creatinine levels,
the renal risk seems to become dominant, and anemia
increases the mortality risk by 70 % if the serum creatin-
ine level is 4.0 mg/dL.
Table 4 Re-classification table (from stage 1 to stage 2) for patients with an expected mortality rate > 50 %
Overall patient population (N = 105)





(higher risk class) (%)
Number re-classified
(lower risk class) (%)
First stage (EuroSCORE II or ACEF score) 20 (19) 7 (35) 14 (13) 12 (11)
Second stage 20 (19) 14 (70)
Non-emergency patients (N = 98)
First stage (EuroSCORE II or ACEF score) 19 (19) 7 (37) 13 (13) 7 (7)
Second stage 13 (13) 9 (69)
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Emergency surgery is a confirmed important factor
determining operative mortality even within the setting
of very high-risk patients. However, in presence of emer-
gency conditions, there is little room available for risk
stratification and decision-making. Therefore, we have
focused our analysis on elective and urgent procedures.
It is not within the purposes of the present study to go
into the details of the mechanisms linking PH, anemia,
and renal function to operative mortality in very high-
risk patients undergoing cardiac surgery. However, it
should be mentioned that these three factors represent
markers of a general severity of the disease and of the
heart function. PH is present in a number of severe con-
ditions summarizing the pattern of both systolic and dia-
stolic heart failure, with specific relationship to left-heart
valve diseases. Anemia is commonly found within the
context of chronic heart failure; additionally, anemia,
heart failure and renal dysfunction are the markers of
the cardio-renal-anemia syndrome.
Clinical perspective
Our findings highlight that in a very small but very im-
portant segment of cardiac surgery patients being at the
top of the operative mortality risk, scores that have been
built in the general patient population are probably inad-
equate. However, it is probably outside the limits of
medical statistics to collect the thousands of patients at
very high risk that would be necessary to design a dedi-
cated risk score. Our approach is a provocative attempt
to overcome this problem using a double-stage risk
stratification strategy.
An interesting point in our analysis pertains the age of
our patients that was on average 74 years. Elderly pa-
tients are more and more referred to cardiac surgery
and will increase dramatically in the next years as a re-
sult of the increased life expectancy. Even if age was not
a significant risk factor at the second stage of risk strati-
fication, a two-stage risk approach may be of particular
value in elderly patients as it highlights a number of risk
factors that are particularly common in the elderly pa-
tient. Within the risk factors increasing the operative
mortality risk in very high-risk cardiac surgery patients,
a specific mention is deserved by preoperative anemia.
Even if both PH and renal dysfunction could theoretic-
ally be improved before surgery, anemia remains cer-
tainly the most modifiable risk factor [16]. Our data
strengthen the need for the implementation of manage-
ment strategies reduce pre-operative risk in high-risk
population. Different strategies can be applied, including
iron supplementation and erythropoietin administration.
Ferric carboxymaltose provides a considerable increase
in hemoglobin values within a reasonable period of time
and could be considered when planning cardiac surgery
in very high-risk patients. However, adequate trials
demonstrating the effectiveness of these strategies in re-
ducing the operative mortality risk in anemic patients
undergoing cardiac surgery are presently lacking.
The present study has a number of limitations. The first
is its retrospective nature; the second, the (relatively) low
number of patients at very high-risk included; the third,
the single-center nature of the study. All these limitations
do not allow generalizability of our results.
Conclusion
The present study does not intend to propose a new
scoring system. The existing models are probably ex-
haustive enough for the great majority of the cardiac
surgery patient population. However, they are inadequate
in those patients (probably no more than 3 % of the gen-
eral patient population) where the operative mortality
risk is so high as to introduce the need for the decision
to proceed with surgery or to follow alternative strat-
egies. Our data stress the role of renal function, PH, and
anemia in determining the actual outcome of these
patients, and provide the surgical team with additional
information to be included in the decision-making process.
Additionally, our data generate the hypothesis that some of
these patients (basically, those with preoperative anemia)
may benefit from a careful “re-training” before surgery,
based on an improvement of the “modifiable” risk factors.
Of course, our data need to be verified in larger patient
population and in different institutions, and further studies
in this area are highly suggested.
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